共 50 条
- [1] Real-World Clinical, Endoscopic, and Safety Outcomes After Upadacitinib Induction for Ulcerative Colitis: A Multicenter Retrospective Cohort Study [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S850 - S851
- [4] Comparative Effectiveness of Upadacitinib vs Ustekinumab for Ulcerative Colitis at 8-16 Weeks: A Multicenter Retrospective Cohort Study [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S628 - S630
- [7] A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis [J]. Journal of Gastroenterology, 2018, 53 : 387 - 396
- [8] Intestinal Ultrasound to Assess Clinical Response After Induction With Upadacitinib in Acute Severe Ulcerative Colitis [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S10 - S10
- [9] One-Year Comparative Effectiveness of Upadacitinib vs Tofacitinib for Ulcerative Colitis: A Multicenter Cohort Study [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (08): : 1628 - 1631